Welcome to Bjornstad Lab
DKD is the leading cause of kidney failure in the U.S. and in Colorado, and the number of people affected have quadrupled over the past 30 years, causing early death. Current medical treatments are only partially protective in patients with T1D and T2D, and T2D and DKD are now rising in youth due to the obesity epidemic. Early in the course of DKD, the filtration elements of the kidneys work excessively, called hyperfiltration, which is common in youth with T1D and T2D. Our research supports strong associations between insulin resistance, which is found in T1D and T2D, and hyperfiltration. We postulate based on our existing research that hyperfiltration increases the kidney’s oxygen and energy needs....
➤ LOCATION
13123 East 16th Avenue B265
Aurora, CO 80045
☎ CONTACT
petter.bjornstad@childrenscolorado.org
petter.m.bjornstad@ucdenver.edu
(720) 777 4659

-
RT @JDRFResearch: Can a drug long-used for type 2 #diabetes, also help those with #T1D? The European body that approves medicines for… https://t.co/3ocA1dR4Fx
-
RT @JDRF: .@amazonsmile has donated over $100M to charities thanks to customers shopping at https://t.co/3OmI3gGkRR. To celeb… https://t.co/9MSZloLBxd
-
RT @NIH: What’s the current state of research from @NIDDKgov? Read the highlights in our Recent Advances & Emerging Opportun… https://t.co/jhRqtcliFs